Estimates suggest that the mass of the population in wealthier countries are likely to be vaccinated against COVID-19 by mid of 2022. However, in poorer economies, mass immunization will take until 2024, if it happens at all.
These countries will pay the cost of this delay in the form of 2.5 million avoidable deaths.
What is standing in the way of expanding production and carrying out mass vaccination campaigns across the world?
- Explained: How Intellectual Property Rights are blocking vaccine production ( Download)
- Podcase: Intellectual Property and COVID Vaccines ( Download)
- Access to vaccines and the limiting role of intellectual property rights and pharma monopolies ( Download)
- Will Scrapping Vaccine Patents Help End the Covid Pandemic | Explain This ( Download)
- U.S. & Other Wealthy Nations Block Effort to Waive Vaccine Patent Rights in Blow to Global South ( Download)
- Dr. Scott Gottlieb on the global fight over Covid vaccine intellectual property ( Download)
- Patents and Pandemics: Innovation Policy and the Patent Waiver Petition at the WTO ( Download)
- Discussion on the Proposed TRIPS Waiver for IP Rights Associated with COVID Vaccines and Treatments ( Download)
- Monopoly patents or vaccines for all ( Download)
- Intellectual Property and Emergencies: Policy for Medicines and Vaccines ( Download)
- The People's Vaccine: Intellectual Property and Access to Medicines in the Age of COVID-19 ( Download)
- Waiving IP for Covid-19 related health products and technologies: prospects and solutions (23/06/21) ( Download)
- How Intellectual Property Has Played a Pivotal Role in the Global COVID-19 Response ( Download)
- From ARVs, Covid-19 Vaccines and Intellectual Property Protections: ( Download)
- The Debate over Intellectual Property Protections for COVID-19 Vaccines after one year | LIVE STREAM ( Download)
